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Background: Maternal cardiovascular and pulmonary events during labor and delivery may result in adverse
maternal and fetal outcome. Potential etiologies include primary cardiac events, pulmonary embolism, eclampsia,
maternal hemorrhage, and adverse medication events. Remifentanil patient-controlled analgesia is an alternative
when conventional neuraxial analgesia for labor is contraindicated. Although remifentanil is a commonly used
analgesic, its use for labor analgesia is not clearly defined.
Case presentation: We present an unexpected and unique case of remifentanil toxicity resulting in the need for
an emergent bedside cesarean delivery. A 30-year-old G3P2 woman receiving subcutaneous heparin
anticoagulation due to a recent deep vein thrombosis developed cardiopulmonary arrest during labor induction
due to remifentanil toxicity.
Conclusion: A rapid discussion among the attending obstetric, anesthesia, and nursing teams resulted in
consensus to perform an emergent bedside cesarean delivery resulting in an excellent fetal outcome. During
maternal cardiopulmonary arrest, a prompt decision to perform a bedside cesarean delivery is essential to avoid
significant maternal and fetal morbidity. Under these conditions, rapid collaboration among obstetric, anesthesia,
and nursing personnel, and an extensive multi-layered safety process are integral components to optimize maternal
and fetal outcomes.
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Emergent bedside cesarean delivery is an intrinsically
unpredictable procedure performed for fetal indications
following a catastrophic event or injury when maternal
survival is uncertain. Under these conditions, a decisive
and cohesive plan of action on the part of labor and de-
livery personnel, including anesthesia, obstetrics, nursing
and neonatology, is linked to fetal and maternal progno-
sis [1]. We present a patient with a history of recent ven-
ous thromboembolism who experienced an unexpected
cardiopulmonary arrest following implementation of an
intravenous remifentanil patient-controlled analgesic
(PCA) infusion for pain relief in labor and subsequently
underwent an emergent bedside cesarean delivery.* Correspondence: kinney.michelle@mayo.edu
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A 30-year-old G3P2 woman was admitted at 38+6 weeks
of gestation for elective induction of labor due to con-
cerns regarding intrapartum anticoagulation. The
current pregnancy was complicated by an episode of
idiopathic lower extremity deep venous thrombosis
(DVT) at 10 weeks estimated gestation at which time an
inferior vena caval (IVC) filter was placed. Following
placement of the IVC filter, therapeutic anticoagulation
was initiated with subcutaneous unfractionated heparin
for the duration of the pregnancy. The remainder of her
antecedent medical history was otherwise unremarkable.
Although the last injection of subcutaneous heparin
was administered 12 h before hospital arrival, the
patient’s activated partial thromboplastin time (aPTT)
was significantly elevated at 70 s (normal range: 21-33 s)
at the time of admission. The patient was subsequently
counseled that neuraxial analgesia was contraindicated
in the setting of an elevated aPTT due to an increasedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ripen the cervix with misoprostol and administer inter-
mittent intravenous (i.v.) fentanyl as needed for labor
analgesia. The fetal heart rate pattern remained reassur-
ing throughout this period of time. A repeat aPTT
obtained 6 h later remained elevated at 80 s. After dis-
cussing potential options with the patient, it was decided
to proceed with i.v. remifentanil patient-controlled anal-
gesia (PCA) based on our institutional protocol (basal
infusion: 0.03-0.05 μg/kg/min; bolus dose 0.2-0.8 μg/kg
every 5 min). A basal infusion rate of 0.04 μg/kg/min
(2 μg/min) with a bolus dose of 0.8 μg/kg (40 μg) every
5 min was ordered based on her ideal body weight of
50 kg. The medication was prepared by the hospital
pharmacy and placed in a barcode syringe for adminis-
tration in a Hospira LifeCareW Infusion System which
was connected to an 18-gauge cannula sited in the
woman’s left hand.
The remifentanil PCA was initiated after appropriate
medication review by anesthesia and nursing personnel,
confirming the drug, concentration, dose, and route of
administration and initiation of pulse oximetry. The
mother was supine, with left uterine displacement.
Within seconds of administering the first PCA dose, the
patient stated that she could not open her eyes and rap-
idly became rigid and apneic. Her oxygen saturation
(SpO2) decreased to approximately 80%, her pulse
declined from 97 to 57 beats/min, and her blood pres-
sure fell from 126/74 to 92/57 mmHg. Anesthesia
personnel immediately performed a jaw-thrust maneuver
to open the patient’s airway and initiated bag-mask ven-
tilation with 100% oxygen at 15 L/min using a flow in-
flating resuscitation bag. Simultaneous to these events,
the hospital code team was summoned by nursing
personnel. The remifentanil infusion was immediately
disconnected and an i.v. bolus of normal saline 500 mL
administered. Two-handed bag-mask ventilation was dif-
ficult due to maternal rigidity, but the patient’s SpO2
improved to >90% within three minutes. Despite appro-
priate resuscitative efforts and maintenance of left
uterine displacement, fetal bradycardia occurred. Subse-
quently, the maternal pulse (radial and femoral) was un-
detectable and fetal cardiac activity was simultaneously
lost. Immediately before initiating cardiopulmonary re-
suscitation (CPR), the maternal pulse returned, preclud-
ing the need for maternal chest compressions. A fetal
scalp electrode did not detect the fetal heart rate. Faculty
members from the Departments of Anesthesiology and
Obstetrics rapidly conferred and decided to proceed
with an emergent bedside cesarean delivery given the
ongoing difficulty with two-handed bag-mask ventila-
tion, non-reassuring fetal status, and concern for further
delay if the patient was transported to an operating
room. The differential diagnosis included massivepulmonary embolus, amniotic fluid embolus, intracranial
hemorrhage, a primary cardiac event, or adverse medica-
tion reaction.
An emergent bedside classical cesarean delivery was
performed through a low midline vertical incision 4 min
after the loss of fetal cardiac activity and 5 min after loss
of maternal cardiac output. Delivery of a term female in-
fant with Apgar scores of 1 and 8 at 1 and 5 min, re-
spectively, followed. Umbilical cord arterial gas analysis
showed a respiratory acidosis with pH 7.07, CO2
89 mmHg, O2 13 mmHg, HCO3 25 mmol/L, and base
deficit of -4 mmol/L. Intravenous etomidate 20 mg and
succinylcholine 120 mg were administered at the time of
surgical incision to facilitate maternal tracheal intub-
ation. There was no patient movement with surgical in-
cision. Following delivery, the patient’s blood pressure
was 136/74 mmHg, her pulse was 135 beats/min, and
her SpO2 was 98%. Initial maternal arterial blood gas
results obtained 6 min after delivery of the infant were:
pH 7.17, CO2 57 mmHg, O2 192 mmHg, HCO3
21 mmol/L, and base deficit -7 mmol/L. Additional i.v.
medications included midazolam 4 mg, ketamine 20 mg,
fentanyl 150 μg, and propofol 40 mg. Maternal pulse
decreased to 71 beats/min and her SpO2 remained >90%
for the remainder of her operation.
The hysterotomy and abdominal wall were temporarily
closed in the labor room and the patient transferred to
the operating room where the abdominal cavity was
inspected. Sevoflurane and oxygen were administered, as
were intravenous oxymorphone 1.4 mg, meropenem
500 mg, and ondansetron 4 mg. After extensive irriga-
tion, the hysterotomy and abdominal incision were
closed using a standard technique. Following closure of
the skin incision, the patient was considered sufficiently
stable for extubation and was taken to the postoperative
recovery room for extended monitoring. The infant was
transferred to the intermediate care nursery for observa-
tion. The patient’s postpartum recovery was complicated
by wound separation with healing by secondary intention.
The patient had no explicit recall of the intraoperative sur-
gical events and she had complete neurologic recovery
with no deficit.
Pharmacy personnel immediately began investigating
the possibility of an adverse medication event. The remi-
fentanil infusion bag and PCA apparatus were collected
and secured as per protocol. Within 3 h of the event, a
medication error was confirmed; the compounded remi-
fentanil solution had a concentration ten-fold higher
than was labeled on the medication syringe. As a result,
the patient had received an i.v. bolus dose of remifenta-
nil 400 μg rather than the 40 μg bolus dose ordered. Fol-
lowing an extensive root cause analysis and patient
event review, Pharmacy Services instituted several safe-
guards and modifications to its compounding protocols
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errors. Specifically, only one concentration of remifenta-
nil is now prepared, and the instructions for preparation
are available on the pharmacy computer without any
mathematical computation required.
Conclusion
During the period 1985-2004, traumatic and cardiac
events were the most common causes of maternal car-
diac arrest and associated perimortem cesarean delivery
[2]. Additional causes included embolism, magnesium
overdose, sepsis, anesthetic events, eclampsia, spontan-
eous uterine rupture, and intracranial hemorrhage. Fetal,
and possibly maternal, outcomes appear optimized by
timely delivery. Cardiopulmonary resuscitation is gener-
ally less effective in the third trimester because of aorto-
caval compression. Emptying the gravid uterus may
ensure better survival of the infant and also allow for
more successful maternal resuscitation; particularly if
the reason for the cardiac arrest is reversible. Published
reports support the long-standing recommendation to
initiate a perimortem cesarean delivery within four min-
utes of maternal cardiopulmonary arrest; with delivery
of the infant within five minutes. This potentially allows
for maternal cerebral oxygenation to be reestablished to
prevent or reduce maternal neurologic damage [2].
The effect of perimortem cesarean section on maternal
circulation in 20 reported cases from 1985-2004 demon-
strated the return of spontaneous circulation or im-
provement in hemodynamic status in 12 (60%) mothers.
There was no change in the hemodynamic status in
eight (40%) mothers where the cause of arrest was lethal
[2]. In our patient, cesarean delivery was started within
four minutes of the loss of the fetal heart trace, and less
than one minute elapsed before delivery. Similar to other
reports, maternal hemodynamics in our case dramatic-
ally improved immediately following delivery.
Although our patient was not undergoing chest com-
pressions at the time of delivery, maternal respiratory ar-
rest, difficult bag-mask ventilation with associated
hypoxemia, profound maternal bradycardia, and loss of
fetal cardiac activity precluded transport to an operating
room. Our management strategy was guided, in part, by
recently published data from the Anesthesia Patient
Safety Foundation (APSF) on maternal cardiac and re-
spiratory arrests [3]. Upon reviewing anesthesia malprac-
tice claims associated with maternal cardiopulmonary
arrests, only 1 (5%) of 22 patients experienced survival
without sequelae or permanent neurologic injury. In that
case, two unique features existed, (1) an anesthesiologist
was present to provide immediate airway management;
and (2) the cesarean delivery was performed in the labor
room within minutes of maternal arrest. Importantly,
transfer of an unstable patient to an operating room forbetter intubating or surgical conditions was not per-
formed, and is currently not recommended [4].
The etiology of our patient’s cardiopulmonary arrest
was acute remifentanil toxicity. Remifentanil is an
ultrashort-acting synthetic opioid compound with an
ester link that confers susceptibility to rapid hydrolysis
by nonspecific tissue and blood esterases, and has a very
short context-sensitive half-life of three minutes [5].
Remifentanil is highly lipid soluble and rapidly crosses
the placenta. The mean remifentanil umbilical vein: ma-
ternal artery concentration ratio of 0.88 suggests signifi-
cant placental transfer of remifentanil. Remifentanil
undergoes rapid redistribution and/or metabolism within
the fetus, with an umbilical arterial to umbilical venous
concentration ratio of 0.29 [6]. In this case, the infant’s
1- and 5- minute Apgar scores improved dramatically
from 1 to 8 exclusively with positive pressure ventilation,
without the need to administer naloxone or other
medications.
During our patient’s event, consideration was given to
an empiric administration of naloxone. However, be-
cause the primary etiology of the maternal arrest was
unknown at the time, the potential benefit to the mother
and baby was uncertain. The complete loss of fetal car-
diac activity suggested that a further delay in delivery
may have resulted in a severely depressed neonate and a
difficult resuscitation. Furthermore, the history of mater-
nal venous thromboembolism increased the likelihood of
a life-threatening embolic etiology. An i.v. dose of nalox-
one 0.4 mg would have been unlikely to result in signifi-
cant improvement in either maternal or fetal condition
given the estimated dose of remifentanil administered
[7]. Naloxone administration in these circumstances
may have only complicated perioperative maternal man-
agement and could have harmed the fetus by delaying
delivery and resuscitation. Our patient’s cardiopulmon-
ary status rapidly improved following delivery, suggest-
ing a reversible, transient etiology rather than an
embolic event. In retrospect, our patient likely had ex-
treme bradycardia with respiratory arrest and rigidity of
her chest wall due to remifentanil toxicity. Complete
cardiac arrest was therefore unlikely.
Rapid teamwork and a multidisciplinary consensus
regarding clinical management are essential components
for optimal maternal and fetal outcome during adverse
maternal events. Routine practice drills and the creation
of dedicated perimortem cesarean equipment packs have
been recommended by some authors [8]. In our case, an
emergency perinatal paging system was activated by our
unit secretary to immediately summon obstetricians,
labor nurses and the obstetric anesthesia and pediatric
teams. Our perinatal group paging system was designed
by Dr. Paula Craigo with the intention of decreasing the
time spent paging multiple care providers, thereby
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ery [9]. Any member of the perinatal team can call our
hospital operator and request perinatal group pager
activation. In this case, ten team members assembled
emergently: an obstetrician, two obstetrical resident phy-
sicians, one anesthesiologist, one nurse anesthetist, one
anesthesiology resident physician, two obstetrical nurses,
one pediatric nurse, and one pediatric physician resident.
One obstetric nurse readied the surgical equipment, an-
other obstetric nurse stayed with the patient’s husband
in a waiting room and provided emotional support, the
obstetricians performed the surgery, the anesthesia pro-
viders managed the patient’s airway, and induced and
maintained the anesthetic, while the pediatrics team
readied their equipment in the infant resuscitation room
and resuscitated the baby. In addition, a hospital-wide
emergency cardiorespiratory arrest group pager system
was also activated by the unit secretary, with response
from six additional team members: a senior anesthesia
resident who supplied additional medications, an inten-
sive care nurse who placed an additional intravenous
line, a respiratory therapist who placed the arterial line,
and three pharmacists who charted vital signs and the
medications that were administered, and who also parti-
cipated in the immediate investigation regarding the
cause of the incident. The teamwork was organized, with
individuals performing their usual role. The anesthesiologist
and obstetrician each led their respective teams, and also
communicated and worked together, calmly sharing deci-
sions such as when to transfer the patient to the operating
suite.
Surgical instruments were obtained by an obstetric
nurse from the operating suite approximately 30 meters
away from the patient’s room. Equipment and medica-
tions to facilitate endotracheal intubation were similarly
obtained by the anesthesiologist from the anesthesia
workroom 30 meters away. Basic airway management
supplies were located in each labor room in a plastic box
in a cupboard. These supplies were utilized, including
in-wall oxygen access and tubing, a flow-inflating venti-
lation bag and mask, and suction equipment.
Remifentanil dosing regimens vary, with patient con-
trolled boluses ranging from 0.2-1 μg/kg, and infusions
of 0.025-0.1 μg/kg/min [10]. Standardized medication
utilization processes for i.v. remifentanil PCA adminis-
tration at our institution include electronic ordering pro-
tocols, concentration and dispensing preparation, and
integration of ‘smart’ infusion pumps with barcode tech-
nology and drug library software. In addition, institu-
tional safety protocols require (1) nursing and anesthesia
team members to be present upon initiation of a remi-
fentanil PCA; and (2) oxygen saturation to be continu-
ously monitored by pulse oximetry. All of the
aforementioned safety features were in place at the timeof our patient’s care and likely contributed to the imme-
diate recognition and successful management of com-
promised maternal status. Finally, our institution
subsequently adopted a policy of conducting twice daily
“Safety Rounds” to familiarize staff with hospitalized
patients and individual care responsibilities.
The relative importance of each of these safety prac-
tices remains unknown; however, their integration into
practice should facilitate immediate maternal resuscita-
tion in conjunction with rapid teamwork and a multidis-
ciplinary approach to patient care, all of which are
essential components to overcome adverse maternal and
fetal events.
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